At NINGBO INNO PHARMCHEM CO.,LTD., we prioritize the safety and efficacy of the excipients we supply. The PVP/VA 64 copolymer, also known as Copovidone, stands out for its excellent safety profile, making it a preferred choice for pharmaceutical formulations and even nutritional supplements.

The established safety of PVP/VA 64 is underscored by its GRAS (Generally Recognized As Safe) status, affirmed by the U.S. Food and Drug Administration (FDA). This designation allows for its use in food and nutritional products, reflecting a high level of confidence in its non-toxicity when consumed appropriately.

Extensive toxicological studies have further validated the safety of this copovidone pharmaceutical excipient. Non-clinical studies conducted on animal models, including rats and dogs, have demonstrated the absence of significant adverse effects even at high dietary levels. These studies have established high no-observed-adverse-effect levels (NOAELs), indicating a wide margin of safety for typical exposures. Furthermore, PVP/VA 64 has shown no irritating or sensitizing effects on the skin, making it suitable for applications with direct contact.

The PVP VA 64 copolymer binder function in pharmaceutical tablets is well-supported by its safety profile. Its use as a dry binder for direct compression, film former, and matrix former for solid dispersions is therefore well-justified from a safety perspective. The vinylpyrrolidone vinyl acetate copolymer uses in pharmaceuticals are safe and effective when manufactured to industry standards.

When formulators choose to buy PVP/VA 64 from NINGBO INNO PHARMCHEM CO.,LTD., they are selecting an excipient with a robust safety dossier. This allows for the development of high-quality, safe, and effective pharmaceutical products and supplements, ensuring consumer well-being and regulatory compliance. The commitment to quality and safety ensures that our PVP/VA 64 continues to meet the stringent requirements of the global health and wellness market.